Apr4
TAI'AN, Shandong Province, China, April 5 /PRNewswire-Asia-FirstCall/ China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China ("PRC"), today announced that its indirect majority-owned subsidiary, Shandong Taibang Biological Products Co. Ltd. ("Shandong Taibang"), has been recognized as one of Shandong's [...]
Feb8
Previously Announced Corporate Name Change to Bohai Pharmaceuticals Group, Inc. Results in New Ticker (OTCBB:BOPH) YANTAI, China(BUSINESS WIRE) Bohai Pharmaceuticals Group, Inc. (Bohai?) (OTCBB:BOPH) today announced that the company’s [...]
Jan31
Company Working to Change Stock Symbol YANTAI, China(BUSINESS WIRE) Link Resources, Inc. (OTCBB: LNKR) today announced that the company has changed its corporate name to Bohai Pharmaceuticals Group, Inc. [...]
Jan4
Yantai Bohai Pharmaceuticals Group Co., Ltd., a Revenue and Profit Generating Traditional Chinese Medicine Company in China, Becomes Link’s Principal Operating Subsidiary CALGARY, Canada & YANTAI, China(BUSINESS WIRE) Link [...]